Company intelligence / Profile preview

NJ Bio, Inc.

Princeton, New Jersey, United Statesnjbio.com ↗

Ownership: Private
Development stage: Other

Overview

NJ Bio provides integrated chemistry and biology services with expertise in ADC development from early discovery through GMP manufacturing. It has been recognized as 'Best Contract Research Organization' at the World ADC Summit for three consecutive years. No direct clinical results since it operates as a service provider rather than developing its own therapeutics.

Modalities: Antibody-drug conjugates (ADCs)synthetic organic moleculesprotein-based biopharmaceuticalslinkerspayloads
Industry: Drug Discovery Services

Partnerships

Charles River Laboratories (strategic alliance for end-to-end ADC development and manufacturing)

Beyond the preview

Go deeper on NJ Bio, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NJ Bio, Inc..

Explore the full profile